Hyaluronidase Versus Adrenaline as an Adjuvant to bupivacaine in Ultrasound-guided Supraclavicular Brachial Plexus Block for Upper Limb Surgeries

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201710002718112

Enrollment

Registered

2017-10-22

Start date

2017-09-06

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Injury, Occupational Diseases, Poisoning Surgery upper limb surgery

Interventions

group (11) (H) ( hyaluronidase group)

group (111) ( A) (Adrenaline group)

group (1) (C)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ¿ Patient acceptance. ¿ Age 20-60 years old. ¿ ASA I and ASA II. ¿ Accepted mental state of the patient. ¿ Elective Unilateral upper limb surgeries below the level of the shoulder.

Exclusion criteria

Exclusion criteria: ¿ Patient refusal. ¿ Pregnancy ¿ ASA Grade 3 and 4 ¿ Neurological deficit involving brachial plexus. ¿ Any bleeding disorder and patient on any anticoagulants. ¿ Local infection at the injection site. ¿ Chronic steroid use. ¿ Severe respiratory disease. ¿ Disturbed conscious level. ¿ History of allergy to local anesthetics or hyaluronidase or adrenaline. ¿ Chronic renal failure

Design outcomes

Primary

Measure	Time frame
¿Time to achieve complete sensory block	—

Secondary

Measure	Time frame
¿ Needling Time;motor block assessment;¿ Surgical anaesthesia ;¿ Total performance time;Duration of analgesia;¿ Duration of motor block;¿ Patient satisfaction	—

Countries

Egypt

Contacts

Public Contactfatma mahmoud ahmed

lecturer

FaTmakasem169@yahoo.com00201095790313

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026